Aurobindo Pharma informs about analyst call

05 Aug 2019

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that an analyst / investor call on the Unaudited Financial Results of the Company for the first quarter ended 30th June 2019 is scheduled on 8th August 2019 at 8:30 AM.

The above information is a part of company’s filings submitted to BSE.

Related Aurobindo Pharma Ltd. Links:

Aurobindo Pharma Share Price

796.60 0.05 (0.01%) Sep 30, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 500.50
Dr. Reddys Lab 5187.05
Lupin 1007.10
Piramal Enterprises 1251.95
Cadila Healthcare 394.90
View more..
Sensex vs Aurobindo Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback